Carcinogenic arsenic, nickel, and chromium compounds induced morphological and neoplastic transformation but no mutation to ouabain resistance in 10T1/2 mouse embryo cells; lead chromate also did not induce mutation to ouabain or 6-thioguanine resistance in Chinese hamster ovary cells. The mechanism of metal-induced morphological transformation was likely not due to the specific base substitution mutations measured in ouabain resistance mutation assays, and for lead chromate, likely not due to this type of base substitution mutation or to frameshift mutations. Preliminary data indicate increases in steady-state levels of c-myc RNA in arsenic-, nickel-, and chromium-transformed cell lines. We also showed that carcinogenic nickel, chromium, and arsenic compounds and N-methyl-N-nitro-N-nitrosoguanidine (MNNG) induced stable anchorage independence (Al) in diploid human fibroblasts (DHF) but no focus formation or immortality. Nickel subsulfide and lead chromate induced Al but not mutation to 6-thioguanine resistance. The mechanism of induction of Al by metal salts in DHF was likely not by the type of base substitution or frameshift mutations measured in these assays. MNNG induced Al, mutation to 6-thioguanine resistance, and mutation to ouabain resistance,and might induce Al by base substitution or frameshift mutations. Dexamethasone, aspirin, and salicylic acid inhibited nickel subsulfide, MNNG, and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced Al in DHF, suggesting that arachidonic acid metabolism and oxygen radical generation play a role in induction of Al. We propose that nickel compounds stimulate arachidonic acid metabolism, consequent oxygen radical generation, and oxygen radical attack upon DNA. Intracellular reduction of Cr(VI) to Cr(V) or other species that generate oxygen radicals leads to Cr(V) or oxygen radical attack upon DNA. Arsenite causes chromosome breaks. We propose that arsenic, nickel, and chromium compounds then cause small deletions or mutations in the 5' or 3' regulatory regions of the c-myc and other protooncogenes, resulting in stabilization of c-myc RNA and higher steady-state levels of c-myc RNA and protein. We also postulate that nickel-induced oxygen radical generation, Cr(V) ions or oxygen radicals generated by chromium, and arsenite induce inactivating mutations or deletions in tumor suppressor genes. Arsenic, nickel, or chromium compound-induced neoplastic transformation is postulated to proceed through a combination of activation of c-myc and/or other protooncogenes and inactivation of tumor suppressor. -Environ Health Perspect 102(Suppl 3):119-125 (1994).
Introduction
Occupational exposure of humans to arsenic, nickel, or chromium compounds correlates with increased frequencies of skin, lung, esophageal, and nasal carcinomas (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , and nickel and insoluble hexa-valent chromium compounds are carcinogenic when administered to animals (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Epidemiological evidence indicates that occupational exposure to arsenic compounds correlates with increased skin and respiratory cancer in humans, but this contrasts with the lack of carcinogenicity of arsenic compounds in animals, presenting an apparent paradox (1, 3, (6) (7) (8) 12 ). These studies have been extended to the cellular level, demonstrating that nickel, hexavalent chromium, and arsenic compounds induce (17) (18) (19) (20) (21) (22) (23) (24) or promote (25) morphological transformation of cultured rodent cells and induce anchorage independence in diploid human fibroblasts (7) (8) (9) (10) 26, 27) .
Significant effort has gone into studying the molecular mechanisms of metal carcinogenesis, and the molecular basis of metal carcinogenesis is beginning to be understood. Metal compounds induce chromosomal aberrations in cultured mammalian cells (28, 29) ; however, except for hexavalent chromium compounds and platinum coordination complexes, carcinogenic metal compounds are inactive or at best weakly active in bacterial and mammalian cell mutagenesis assays (7, 8, 30) . The in vitro mammalian and bacterial mutagenesis assays currently available do not effectively detect the DNA alterations caused by carcinogenic metal salts (28, 29) . In this manuscript, I review recent studies from my laboratory on induction of morphological transformation in C3H/1OTl/2 Cl 8 (1OTl/2) mouse embryo cells and anchorage independence in diploid human fibroblasts by carcinogenic metal salts and hypothesize the possible mechanisms of metal salt-induced cell transformation.
Materials and Methods
C3H/1OTl/2 Cl 8 mouse embryo fibroblasts were cultured according to the meth-ods of Reznikoff et al. (31) . Assays were conducted to quantitate chemically induced cytotoxicity and morphological transformation (23, 24, 32, 33, 34) . Assays to detect chemically induced mutation to ouabain resistance in 1OTl/2 cells were performed as previously reported (23, 24, 33) . Diploid human fibroblasts were derived from circumcised human foreskins and cultured according to the methods of Biedermann and Landolph (26, 24 . Assays to detect metal-induced cytotoxicity, anchorage independence, and mutation to 6-thioguanine resistance and ouabain resistance were also as described by Biedermann and Landolph (26, 27 (7, 8, 23, 24, (32) (33) (34) (35) . They are also a useful model cell culture system used to study the mechanisms of chemically induced neoplastic transformation and to detect carcinogens by their ability to induce morphological transformation of these cells (7, 8, 34, 35) .
We have been studying the ability of carcinogenic metal salts to induce morphological transformation of 10T1/2 cells to gain insight into the mechanisms of metal carcinogenesis. Our cumulative studies indicate that carcinogenic arsenic, nickel, and chromium compounds induce morphological transformation of 1OT1/2 cells (7, 8) .
We first examined the ability of 1OT1/2 cells to phagocytose carcinogenic insoluble nickel compounds. We found that 10T1/2 cells readily phagocytose nickel subsulfide particles, and the phagocytosed particles can be readily seen in phagocytic vesicles (Figure 1 ). The phagocytosis of nickel subsulfide and crystalline nickel monosulfide by 1OT1/2 cells occurs when low concentrations of these compounds (0-50 pM) are added to the medium ( Figure 2A ) (24) . Over the concentration range that phagocytic uptake of nickel compounds occurs, we also observed a concentration dependent cytotoxicity in 1OT1/2 cells treated with the insoluble nickel compounds nickel subsulfide and nickel monosulfide ( Figure 2B ), With nickel oxide. we did not observe discrete phagocytic vesicles, but nevertheless, we observed cytotoxicity in 1OT1/2 cells treated with from 0 to 1 mM nickel oxide ( Figure 28 ) (24) .
We next studied the ability of carcinogenic nickel compounds to induce morphological transformation in 10T1/2 cells (24) (24) .
Conversely, the soluble nickel compounds nickel sulfate and nickel chloride, which are noncarcinogenic or substantially less carcinogenic than the insoluble nickel compounds, did not induce morphological transformation of 1OT1/2 cells (7, 8, 24 We previously developed an assay detecting chemically induced (33) stable (36) , specific (37) base substitution mutations (38) to ouabain resistance that results from a mutation in a gene encoding (Na,K)-ATPase activity on murine chromosome 3 (39) and confers a ouabain- fide-and nickel oxide-transformed 1OT1/2 cell lines frequently express higher steadystate levels of c-myc RNA (Table 2) . We hypothesize that transformation of 1OT1/2 cells by nickel compounds results in small deletions or small mutations in the 3' or 5' regulatory regions of the c-myc and c-H-ras protooncogenes, leading to activation of these protooncogenes via this mechanism and hence a stabilization of the protooncogene RNAs and the increased steady-state levels and increased half-lives of these mRNAs that we observe. Studies to test this hypothesis critically in our laboratory are in progress (T Sakuramoto, D Evans, T Miura, S Boone, and JR Landolph, unpublished data).
We were also able to show that lead chromate induced a low but dose-dependent and reproducible frequency of type III morphological transformation (23) (23) . This indicated that unique physicochemical properties of insoluble lead chromate particles were responsible for its uptake, likely by phagocytosis, and its ability to induce cytotoxicity and cell transformation (23) , and correlated with earlier observations that the slightly soluble hexavalent chromlum compounds are also carcinogenic in animal bioassays (4, 5, 7, 8) .
We showed that lead chromate induced morphological transformation in 10T1/2 cells but not mutation to ouabain resistance in 10TI/2 or CHO cells nor mutation to 6-thioguanine resistance in CHO cells (23) . In addition, calcium chromate did not induce morphological transformation in 1OT1/2 cells or mutation to ouabain resistance in 10T1/2 or CHO cells but did induce mutation to 6-thioguanine resistance in CHO cells (23 (26, 27) . The specificity of carcinogenic metal salt-induced Al is indicated by the fact that manganese chloride, mercuric acetate, and calcium chloride, which are not carcinogenic, did not induce AI (27) .
Nickel subsulfide did not induce mutation to ouabain resistance or to 6-thioguanine resistance (26) and lead chromate did not induce mutation to 6-thioguanine resistance (27) at concentrations that were cytotoxic, and induced AI in diploid human fibroblasts. Hence, nickel subsulfide and lead chromate likely induced anchorage independence by mutations of the type not easily measured in assays for 6-thioguanine resistance. We speculate that metal-induced oxygen radical generation and consequent radical-induced mutations might be part of the mechanism of nickel subsulfide and lead chromate-induced Al in diploid human fibroblasts. Calcium chromate, potassium dichromate, and MNNG did induce mutation to 6-thioguanine resistance and AI over the same concentration ranges, indicating that mutation might be a mechanism by which these compounds induced AI (27) .
Recently, we have begun to test the hypothesis that stimulation of arachidonic acid metabolism and consequent generation of oxygen radicals are part of the molecular mechanism by which metal compounds induce AI in diploid human fibroblasts. We have found that nickel subsulfide-induced AI in human fibroblasts was inhibited by dexamethasone, aspirin, and nordihydroguaieretic acid. Similarly, MNNG-induced AI was also inhibited by these three inhibitors of arachidonic acid release (dexamethasone) and metabolism (aspirin, which inhibits cyclooxyenase activity) and oxygen radical persistence [salicylic acid, which scavenges oxygen radicals (40)]. In addition, the tumor promoter TPA induced Al only when applied to the soft agar, and the TPA-induced anchorage-independent phenotype was reversible and only manifested in the presence of TPA. However, induction of AI by TPA was also inhibited by dexamethasone and aspirin (RA Biedermann, JO Nwankwo, J Weng, and JR Landolph, unpublished data; summarized in Table 3 ).
Conclusions
It is very clear that the mechanisms of metal carcinogenesis are complex and only beginning to become understood, and that the mechanisms of carcinogenesis for each metal are specific to that metal (44) . With Environmental Health Perspectives these considerations in mind, however, a number of conclusions and interesting speculations may be drawn from the work in our laboratory on mechanisms of metalinduced cell transformation. For the carcinogenic insoluble nickel compounds such as nickel subsulfide, we (24) and others (17, 18) have evidence that these compounds are phagocytosed and that large amounts of these compounds are therefore taken up into individual murine (24) , hamster (17, 18) , and human (26) Since we have found that sodium arsenite does not induce mutation to ouabain resistance in 1OT1/2 cells (R Landolph and C Troesch, unpublished data), we again postulate that arsenite induces mutations in 3' or 5' regulatory regions of the c-myc gene in these transformed cell lines. The precise mechanism by which arsenite induces such mutations is not clear. Work in our laboratory is currendy in progress to determine the type of mutations arsenite induces in the cmyc gene that contributes an increased halflife of c-myc RNA and to maintenance of the transformed phenotype (M Dews and JR Landolph, unpublished data).
In the case of arsenic-, nickel-, and chromium-induced cell transformation, we postulate that these compounds also cause mutation and/or deletions in tumor suppressor genes that inactivate these genes. We postulate that a combination of mutation or deletion induces activation of single or multiple protooncogenes into oncogenes, plus a mutational or deletional inactivation of tumor suppressor genes, is part of the mechanism of metal carcinogenesis.
